Skip to main
LMND

Lemonade (LMND) Stock Forecast & Price Target

Lemonade (LMND) Analyst Ratings

Based on 6 analyst ratings
Buy
Strong Buy 17%
Buy 33%
Hold 50%
Sell 0%
Strong Sell 0%

Bulls say

Lemonade is using technology, data, artificial intelligence, contemporary design, and social impact to deliver affordable insurances and ensure transparency in handling policies and claims. With strong financial performance in the first quarter of 2026 and guidance for continued growth, the company is proving itself as the AI and digital leader in the insurance industry with structural advantages. The company also has a potential for cross-selling and increasing average values, presenting an asymmetric risk/reward opportunity as the company strives towards profitability and may see multiple expansions.

Bears say

Lemonade is a fast-growing insurance company that utilizes technology, data, and artificial intelligence to provide transparent and affordable insurance policies. Despite 1Q26 reporting higher than expected revenue, in-force premiums, and adjusted EBITDA, the company is projected to have negative EBITDA and a high stock-based compensation expense in both FY-2026 and 2Q26. Additionally, Lemonade's status as a public benefit corporation and its reliance on AI for underwriting and claims handling may make it vulnerable to potential technological disruptions and evolving regulations.

Lemonade (LMND) has been analyzed by 6 analysts, with a consensus rating of Buy. 17% of analysts recommend a Strong Buy, 33% recommend Buy, 50% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Lemonade and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Lemonade (LMND) Forecast

Analysts have given Lemonade (LMND) a Buy based on their latest research and market trends.

According to 6 analysts, Lemonade (LMND) has a Buy consensus rating as of Aug 25, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $66.17, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $66.17, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Lemonade (LMND)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.